Vital Signs — Thursday, October 22, 2026

"How much time he gains who does not look to see what his neighbour says or does or thinks." — Marcus Aurelius, Meditations

(Attention is the day's scarcest drug — spend it on your own patients, not other people's fires.)

Editor's Pick

By the Numbers

  • 29,000 — doses of heartworm prevention Virbac donated to KC Pet Project, enough to cover every dog through its doors; takeaway: the shelter also hands adopters of heartworm-positive dogs a full year of meds — a reminder that prevention partnerships are cheap at scale and worth asking your own reps about.

In the Journals

  • A pill to help dogs live longer moves closer to FDA approval — Loyal's LOY-002, a daily pill aimed at extending healthy lifespan in dogs 10+ years and 14+ lbs, has cleared the FDA's safety review and "reasonable expectation of effectiveness" bar on the path to conditional approval — manufacturing review and a longevity trial still stand between it and your pharmacy.
  • Review proposes response-guided precision nutrition for dogs and cats — A new review in Frontiers in Veterinary Science argues companion-animal nutrition should move from one-size formulas to response-guided feeding, with monitoring measures like weight, condition score, and urinary chemistry being the practical starting points today.
  • Comparative Veterinary Psychopharmacology in Dogs and Cats — A 26-page review maps how behavioral drugs differ between dogs and cats by neurotransmitter target and metabolism — evidence runs stronger for dogs, and the authors warn against borrowing human-psychiatry dosing logic for either species.

The Business End

The Fine Print

The Feel-Good Finish

Know an independent practice owner? Forward this.

Read more

© 2026 Vital Signs. Forwarding to a colleague is welcome; please don't republish without permission.